Home/Capabilities
Capabilities
One capability, applied across the product lifecycle.
Most regulatory problems are not solved by a single service. They need scientific judgment, operational discipline and digital capability working together. That is how we are organised.
The integrated model
Why we do not sell these separately
A submission delayed by a labelling inconsistency is not a labelling problem. It is a process problem, a data problem and a governance problem that happened to surface in labelling.
Regulatory consultancies tend to sell expertise by the hour. Technology vendors tend to sell a platform and leave the operating model to you. Neither closes the gap on its own, because the gap is usually between them.
We work across all three pillars in a single engagement: the regulatory judgment to know what good looks like, the operational thinking to make it repeatable, and the digital capability to stop it depending on individual heroics.
Service areas
What we actually do
Grouped by the three pillars. Every area connects to the others — the links between them are where most of the value sits.
Regulatory excellence
The scientific and regulatory foundation. Getting the position right before anything is submitted.
Regulatory strategy
Pathways and sequencing across US, EU and rest-of-world markets. Pre-IND and formal FDA meetings, EMA scientific advice, WHO and reliance routes.
CMC and quality
Module 3 authoring and review, specification and stability strategy, comparability assessment, and post-approval CMC change classification across markets.
Publishing and submission
Dossier planning and compilation, Module 1 authoring, eCTD publishing and technical validation, gateway submission, and lifecycle sequence integrity.
Labelling
Core data sheets, regional product information, structured product labelling, review and portfolio-level labelling operations. Our deepest single service line.
Lifecycle management
Variations, renewals and transfers across markets — including grouping, super-grouping and worksharing under the revised EU variations framework.
Raw material compliance
Risk-based qualification across APIs, excipients, botanicals and supplement ingredients — supplier oversight, specifications, contaminant strategy and lifecycle monitoring.
Regulatory intelligence
Requirement monitoring across target markets, change-impact assessment against your portfolio, and translation of new guidance into concrete actions for your teams.
Digital transformation
Making regulatory work connected, visible and repeatable rather than dependent on individuals.
Applied AI and automation
Where machine assistance genuinely helps — document comparison, gap analysis, data extraction — with the validation and oversight that regulated work requires.
RIM strategy and implementation
Regulatory information management selection, migration from legacy trackers and spreadsheets, and the governance needed to keep the data trustworthy afterwards.
Process redesign
Mapping how regulatory work actually flows, removing handoffs that add delay without adding control, and rebuilding processes around decisions rather than documents.
Structured content management
Moving from document-first to component-first authoring, so a single approved statement can be reused across submissions, labels and markets rather than retyped and re-reviewed.
Regulatory data and analytics
Portfolio-level visibility of registrations, commitments and deadlines. Making it possible to answer questions about the portfolio without a two-week manual exercise.
Operating model design
Scalable delivery models across in-house, offshore and partner teams, with clear ownership, quality expectations and escalation routes.
Innovation
Preparing for what is coming, grounded in regulatory problems that actually exist.
Emerging regulatory frameworks
Readiness assessment for changing requirements — structured data submissions, electronic product information and evolving expectations for computerised systems.
Proofs of concept
Short, bounded experiments against a real regulatory problem, designed to produce evidence about whether an approach works before it becomes a programme.
Responsible innovation advisory
Where new technology can and cannot be used in regulated processes: validation expectations, data integrity, auditability and human oversight.
How we engage
Four ways to start
Engagements differ in shape, not in standard. Each one begins with the decision you are trying to make.
Advisory
Senior regulatory judgment on a specific question — a pathway, a classification, a health authority position. Short, focused, and often the right first step.
Project delivery
A defined deliverable with a defined end: a submission, a labelling implementation, a system migration, a process redesign.
Managed capability
An ongoing team operating a regulatory function or sub-function to agreed quality and service expectations, with your governance over it.
Transformation programme
Multi-workstream change across process, data, technology and people, sequenced so that operations keep running while the change lands.
Where to go next
Related routes
Bring us the challenge
Start with the problem, not the service line.
Tell us the decision or constraint in front of you and we will tell you which of these capabilities is actually relevant — including when the answer is none of them.

